ACES Diagnostics
PrivateLast Round
Seed Round
May 5, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ACES Diagnostics operates in Healthcare & Life Sciences and is based in Paradise Valley, Arizona. It was founded in 2017.
ACES Diagnostics, Inc. is a healthtech company that develops diagnostic testing technologies for the early detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ACES Diagnostics Comparables
Compare ACES Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlueArc Biosciences | 87% | |
| Vibrant Sciences LLC | 79% | |
| IGeneX | 78% |
For institutional investors. Book with your work email.
ACES Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ACES Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bay Area Lyme Foundation | Seed Round |
| AZAdvances | Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
$400K raised in Seed Round.
- Dec 23, 2025
Grew 75% QoQ from 4 to 7 employees.
For institutional investors. Book with your work email.
ACES Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ACES Diagnostics's valuation, stock price, and market status.
Is ACES Diagnostics a public or private company?
ACES Diagnostics is a private company.
What is the current stock price of ACES Diagnostics?
ACES Diagnostics is a private company, so its shares have no public market price. Caplight tracks ACES Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ACES Diagnostics worth (valuation)?
Valuation information for ACES Diagnostics is not publicly available.
Can I buy ACES Diagnostics stock?
ACES Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ACES Diagnostics's last funding round?
ACES Diagnostics's most recent funding round was Seed Round on May 5, 2026.
Who are the main investors in ACES Diagnostics?
Key investors in ACES Diagnostics include Bay Area Lyme Foundation, AZAdvances.
Will ACES Diagnostics IPO soon?
No public IPO plans have been announced for ACES Diagnostics.
How can I track ACES Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in ACES Diagnostics's shares on secondary markets.